TYPE 2 HEPATORENAL SYNDROME

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
Various vasoconstrictors have shown promising results in the management of type 1 hepatorenal syndrome (HRS). However, there are very few studies on vasopressors in the management of type 2 HRS. Terlipressin has been used commonly; however it is costly and not available in some countries. In the present study, the investigators evaluated safety and efficacy of terlipressin and noradrenaline in the treatment of type 2 HRS
Epistemonikos ID: e40eabd26ccf9665e144b691339f9f5cc1fe3a16
First added on: Nov 21, 2014